Evidence map›Paper›PMID 39391907›Full record

ArticleClinical and molecular hepatology2025

Metabolic dysfunction-associated steatotic liver disease exhibits sex-specific microbial heterogeneity within intestinal compartments.

Carlos Jose Pirola, Maria Silvina Landa, Mariano Schuman, Silvia Inés García, Adrian Salatino, Silvia Sookoian

Abstract read
In one paragraph

Article in Clinical and molecular hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Sex and gender differences in metabolic dysfunction-associated liver disease.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Carlos Jose PirolaSystems Biology of Complex Diseases, Translational Research in Health Center (CENITRES). Maimónides University, Buenos Aires, Argentin.
Maria Silvina LandaNational Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina.
Mariano SchumanNational Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina.
Silvia Inés GarcíaNational Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina.
Adrian SalatinoMax Planck Institute for Immunobiology and Epigenetics, Bioinformatics Facility, Frieburg, Germany.
Silvia SookoianNational Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina.

Funding

Agencia Nacional de Promoción Científica y TecnológicaConsejo Nacional de Investigaciones Científicas y Técnicas PUE 0055Fondo para la Investigación Científica y Tecnológica PICT 2018-00620Fondo para la Investigación Científica y Tecnológica PICT 2018-889Fondo para la Investigación Científica y Tecnológica PICT 2019-0528Fondo para la Investigación Científica y Tecnológica PICT 2020-SerieA-0799
6 · The paper itself

Abstract

BACKGROUND/

aimsEvidence suggests that the gastrointestinal microbiome plays a significant role in the biology of metabolic dysfunction-associated steatotic liver disease (MASLD). However, it remains unclear whether disparities in the gut microbiome across intestinal tissular compartments between the sexes lead to MASLD pathogenesis.

methodsSex-specific analyses of microbiome composition in two anatomically distinct regions of the gut, the small intestine and colon, were performed using an experimental model of MASLD. The study involved male and female spontaneously hypertensive rats and the Wistar-Kyoto control rat strain, which were fed either a standard chow diet or a high-fat diet for 12 weeks to induce MASLD (12 rats per group). High-throughput 16S sequencing was used for microbiome analysis.

resultsThere were significant differences in the overall microbiome composition of male and female rats with MASLD, including variations in topographical gut regions. The beta diversity of the jejunal and colon microbiomes was higher in female rats than in male rats (PERMANOVA p-value=0.001). Sex-specific analysis and discriminant features using LEfSe showed considerable variation in bacterial abundance, along with distinct functional properties, in the jejunum and colon of animals with MASLD. Significantly elevated levels of lipopolysaccharide and protein expression of Toll-like receptor 4 were observed in the livers of male rats with MASLD compared with their female counterparts.

conclusionThis study uncovered sexual dimorphism in the gut microbiome of MASLD and identified microbial heterogeneity within intestinal compartments. Insights into sex-specific variations in gut microbiome composition could facilitate customised treatment strategies.

Indexed as

Fatty LiverGastrointestinal MicrobiomeAnimalsColonDiet, High-FatDisease Models, AnimalFemaleJejunumLiverMaleRatsRats, Inbred SHRRats, Inbred WKYRNA, Ribosomal, 16SSex FactorsToll-Like Receptor 4RNA, Ribosomal, 16SToll-Like Receptor 4Gut microbiomeMASLDMetabolic syndromeNAFLDSexual dimorphism

Identifiers

PMID39391907
PMCPMC11791572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.